Molecular biomarkers of risk in rare and other cancers – identification and impact | Zendy

Joanna Selfe | Zendy; Janet Shipley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Molecular biomarkers of risk in rare and other cancers – identification and impact

Author(s) -

Joanna Selfe,

Janet Shipley

Publication year - 2016

Publication title -

the biochemist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.126

H-Index - 7

eISSN - 1740-1194

pISSN - 0954-982X

DOI - 10.1042/bio03801010

Subject(s) - identification (biology) , computational biology , profiling (computer programming) , medicine , bioinformatics , biology , risk analysis (engineering) , intensive care medicine , computer science , botany , operating system

Cancer medicine is evolving rapidly. Advances in gene sequencing and profiling technology now means that we can obtain vast amounts of information about the genetic makeup of individual tumours and harness this to both predict which patients are at most risk of failing to be cured by current treatments and to tell us which of the myriad of new drugs targeted at individual proteins and pathways may be the most effective treatment in a highly patient-specific approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research